Candriam SCA’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Candriam SCA’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-155,972	Closed	-$21.3M	–	864
2020 Q3	$21.3M	Buy	155,972 +17,972	+13%	+$1.91M	0.2%	129
2020 Q2	$13.3M	Buy	138,000 +67,500	+96%	+$5.63M	0.14%	170
2020 Q1	$5.02M	Hold	70,500	–	–	0.06%	344
2019 Q4	$5.14M	Buy	70,500 +9,500	+16%	+$576K	0.06%	351
2019 Q3	$3.18M	Hold	61,000	–	–	0.04%	408
2019 Q2	$3.04M	Hold	61,000	–	–	0.04%	434
2019 Q1	$3.17M	Hold	61,000	–	–	0.04%	407
2018 Q4	$2.98M	Hold	61,000	–	–	0.05%	377
2018 Q3	$3.98M	Hold	61,000	–	–	0.05%	371
2018 Q2	$3.03M	Hold	61,000	–	–	0.05%	393
2018 Q1	$2.98M	Sell	61,000 -37,000	-38%	-$1.92M	0.05%	390
2017 Q4	$4.13M	Sell	98,000 -8,000	-8%	-$308K	0.07%	305
2017 Q3	$4.54M	Buy	+106,000	New	+$3.38M	0.08%	282

Candriam SCA's MYOK Position: Q4 2020 in Review

Candriam SCA sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 155,972 shares — an estimated $21.3M sold.

Candriam SCA first reported a position in MYOK in Q3 2017 and held it in 13 quarters. The position peaked at $21.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Candriam SCA reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Candriam SCA sold 155,972 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $21.3M.
Candriam SCA first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 13 quarters.
Candriam SCA's MyoKardia, Inc. Common Stock position peaked at $21.3M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Candriam SCA's 13F filing for Q4 2020, filed 22 Jan 2021.